Efficacy of adalimumab as first-line therapy in pediatric Crohn's disease. Issue 4 (October 2017) - Zenzeri, L.; Pigneur, B.; Norsa, L.; Farinelli, E.; Esposito, S.; Ruemmele, F.M.